Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

Mian, S., Ugurel, S., Parkinson, E., Schlenzka, I., Dryden, I., Lancashire, L., Ball, G. ORCID: 0000-0001-5828-7129, Creaser, C., Rees, R. and Schadendorf, D., 2005. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology, 23 (22), pp. 5088-5093. ISSN 0732-183X

Full text not available from this repository.
Item Type: Journal article
Publication Title: Journal of Clinical Oncology
Creators: Mian, S., Ugurel, S., Parkinson, E., Schlenzka, I., Dryden, I., Lancashire, L., Ball, G., Creaser, C., Rees, R. and Schadendorf, D.
Publisher: American Society of Clinical Oncology
Place of Publication: Alexandria, VA
Date: 2005
Volume: 23
Number: 22
ISSN: 0732-183X
Identifiers:
NumberType
10.1200/JCO.2005.03.164DOI
Divisions: Schools > School of Science and Technology
Depositing User: EPrints Services
Date Added: 09 Oct 2015 10:58
Last Modified: 09 Jun 2017 13:46
URI: http://irep.ntu.ac.uk/id/eprint/20830

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year